Superior制服集团 SGC 深 沪
等待开盘 10-31 09:30:00 美东时间
9.56
-0.110
-1.14%
华盛通- 最 高10.0972
- 今 开9.61
- 成交量 2.77万股
- 最 低 9.4501
- 昨 收 9.67
- 总市值 1.53亿
- 52周最高 17.18
- 市盈率 静 13.14
- 换手率 0.17%
- 52周最低 8.83
- 委 比 42.86%
- 总股本 1596.83万
- 历史最高 26.89
- 量 比 0.92
- 振 幅 6.69%
- 历史最低 0.0375
- 每 手 1
- 风险率 2.42%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Pfizer Blasts Novo Nordisk's $9 Billion Counteroffer For Metsera As 'Reckless'
Novo Nordisk's $9 billion offer for Metsera challenges Pfizer's existing merger deal, prompting sharp criticism and potential legal action.
10-30 23:39
Enbridge Line 5 reroute around Wisconsin reservation approved by U.S. Army Corps
The U.S. Army Corps of Engineers on Wednesday approved Enbridge's (ENB) application to reroute the aging Line 5 oil pipeline around a northern Wisconsin tribal reservation. Enbridge's (ENB) 41-mile re...
10-30 22:51
Metsera Considers Novo Nordisk’s Superior Proposal
Metsera, Inc. ( ($MTSR) ) just unveiled an announcement. On October 29, 2025, M...
10-30 19:59
Metsera Receives Unsolicited Proposal from Novo Nordisk
Metsera Declares Novo Nordisk Proposal "Superior" Novo Nordisk Proposal Values Metsera at up to $77.75 per Share, a Total of Approximately $9 Billion Pursuant to Pfizer Merger Agreement, Met...
10-30 19:07
Alphabet Q3 Earnings Ahead: Analysts see upside from AI innovation
Tech conglomerate Alphabet (NASDAQ:GOOG) is set to announce its third-quarter earnings on Wednesday, October 29th, after the closing bell, with analysts expecting the company to report earnings per sh...
10-28 23:17
Humain hopes to reboot tech landscape with AI-based operating system: report
Humain, an artificial intelligence startup based in Saudi Arabia, hopes to change the way users interact with computers as it prepares to launch an AI-based operating system that follows vocal command...
10-27 21:53
重大突破！舜景医药「全球首创」急性心梗抗体药SGC001Ib期临床研究取得积极结...
近日，热景生物参股公司北京舜景生物医药技术有限公司（简称“舜景医药”）研制的全球首创急性心梗抗体药SGC001注射液Ib期临床研究获得积极的初步结果。数据显示...
10-27 20:30
Eli Lilly's New Ebglyss Results Back Flexible Treatment Options For Atopic Dermatitis
Eli Lilly reports new data showing sustained efficacy for Ebglyss with less frequent dosing and strong long-term results for Olumiant in hair regrowth.
10-25 00:06
Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark
Sanofi Q3 sales beat estimates on strong Dupixent and new drug demand; reaffirms 2025 outlook with double-digit EPS growth expected.
10-24 22:47
公司简介
公司名称
|
Superior制服集团
|
行业分类
|
服装零售
|
业务描述
|
Superior Group of Cos., Inc. engages in the manufacture and sale of uniforms, corporate identity apparel, career apparel, and accessories to the medical and health fields as well as for the industrial, commercial, leisure, and public safety industries. It operates through the following segments: Branded Products, Healthcare Apparel, and Contact Centers. The Branded Products segment produces and sells customized merchandising solutions, promotional products and branded uniform programs. The Healthcare Apparel segment manufactures and sells a wide range of healthcare apparel, such as scrubs, lab coats, protective apparel and patient gowns. The Contact Centers segment offers outsourced, nearshore business process outsourcing, contact and call-center support services. The company was founded in 1920 and is headquartered in St. Petersburg, FL.
|
Pfizer Blasts Novo Nordisk's $9 Billion Counteroffer For Metsera As 'Reckless'
Novo Nordisk's $9 billion offer for Metsera challenges Pfizer's existing merger deal, prompting sharp criticism and potential legal action.
10-30 23:39
Enbridge Line 5 reroute around Wisconsin reservation approved by U.S. Army Corps
The U.S. Army Corps of Engineers on Wednesday approved Enbridge's (ENB) application to reroute the aging Line 5 oil pipeline around a northern Wisconsin tribal reservation. Enbridge's (ENB) 41-mile re...
10-30 22:51
Metsera Considers Novo Nordisk’s Superior Proposal
Metsera, Inc. ( ($MTSR) ) just unveiled an announcement. On October 29, 2025, M...
10-30 19:59
Metsera Receives Unsolicited Proposal from Novo Nordisk
Metsera Declares Novo Nordisk Proposal "Superior" Novo Nordisk Proposal Values Metsera at up to $77.75 per Share, a Total of Approximately $9 Billion Pursuant to Pfizer Merger Agreement, Met...
10-30 19:07
Alphabet Q3 Earnings Ahead: Analysts see upside from AI innovation
Tech conglomerate Alphabet (NASDAQ:GOOG) is set to announce its third-quarter earnings on Wednesday, October 29th, after the closing bell, with analysts expecting the company to report earnings per sh...
10-28 23:17
Humain hopes to reboot tech landscape with AI-based operating system: report
Humain, an artificial intelligence startup based in Saudi Arabia, hopes to change the way users interact with computers as it prepares to launch an AI-based operating system that follows vocal command...
10-27 21:53
重大突破！舜景医药「全球首创」急性心梗抗体药SGC001Ib期临床研究取得积极结...
近日，热景生物参股公司北京舜景生物医药技术有限公司（简称“舜景医药”）研制的全球首创急性心梗抗体药SGC001注射液Ib期临床研究获得积极的初步结果。数据显示...
10-27 20:30
Eli Lilly's New Ebglyss Results Back Flexible Treatment Options For Atopic Dermatitis
Eli Lilly reports new data showing sustained efficacy for Ebglyss with less frequent dosing and strong long-term results for Olumiant in hair regrowth.
10-25 00:06
Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark
Sanofi Q3 sales beat estimates on strong Dupixent and new drug demand; reaffirms 2025 outlook with double-digit EPS growth expected.
10-24 22:47
派息除权日
|
每股总股息
| 派息日期 |
2025-08-18
|
0.14
|
2025-08-29
|
2025-05-19
|
0.14
|
2025-05-30
|
2025-02-18
|
0.14
|
2025-02-28
|
2024-11-13
|
0.14
|
2024-11-27
|
2024-08-16
|
0.14
|
2024-08-30
|
2024-05-17
|
0.14
|
2024-06-03
|
2024-02-22
|
0.14
|
2024-02-29
|
2023-11-21
|
0.14
|
2023-12-06
|
2023-08-24
|
0.14
|
2023-09-08
|
2023-05-18
|
0.14
|
2023-06-02
|
2023-02-13
|
0.14
|
2023-02-28
|
2022-11-17
|
0.14
|
2022-12-02
|
2022-08-18
|
0.14
|
2022-09-02
|
2022-05-23
|
0.14
|
2022-06-07
|
2022-02-11
|
0.12
|
2022-02-25
|
2021-11-18
|
0.12
|
2021-11-30
|
2021-08-17
|
0.12
|
2021-09-01
|
2021-05-27
|
0.12
|
2021-06-11
|
2021-02-11
|
0.10
|
2021-02-26
|
2020-11-13
|
0.10
|
2020-11-30
|
2020-08-10
|
0.20
|
2020-08-25
|
2020-02-11
|
0.10
|
2020-02-26
|
2019-11-12
|
0.10
|
2019-11-27
|
2019-08-13
|
0.10
|
2019-08-28
|
2019-05-14
|
0.10
|
2019-05-29
|
2019-02-12
|
0.10
|
2019-02-27
|
2018-11-13
|
0.10
|
2018-11-28
|
2018-08-14
|
0.10
|
2018-08-29
|
2018-05-15
|
0.09
|
2018-05-30
|
2018-02-13
|
0.09
|
2018-02-28
|
2017-11-14
|
0.09
|
2017-11-29
|
2017-08-14
|
0.09
|
2017-08-30
|
2017-05-15
|
0.09
|
2017-05-31
|
2017-02-13
|
0.09
|
2017-03-01
|
2016-11-14
|
0.09
|
2016-11-29
|
2016-08-15
|
0.09
|
2016-08-31
|
2016-05-16
|
0.08
|
2016-05-31
|
2016-02-12
|
0.08
|
2016-03-01
|
2015-11-16
|
0.08
|
2015-11-30
|
2015-08-10
|
0.08
|
2015-08-31
|
2015-05-11
|
0.08
|
2015-05-26
|
2015-02-13
|
0.08
|
2015-03-02
|
2014-11-17
|
0.15
|
2014-12-01
|
2014-08-11
|
0.15
|
2014-08-25
|
2014-05-12
|
0.14
|
2014-05-27
|
2014-02-14
|
0.14
|
2014-03-03
|
2013-11-08
|
0.14
|
2013-11-25
|
2012-12-19
|
0.54
|
2012-12-31
|
2012-11-09
|
0.14
|
2012-11-26
|
2012-08-13
|
0.14
|
2012-08-27
|
2012-05-14
|
0.14
|
2012-05-29
|
2012-02-13
|
0.14
|
2012-02-27
|
2011-11-14
|
0.14
|
2011-11-28
|
2011-08-15
|
0.14
|
2011-08-29
|
2011-05-16
|
0.14
|
2011-05-31
|
2011-02-14
|
0.14
|
2011-02-28
|
2010-11-15
|
0.14
|
2010-11-29
|
2010-08-16
|
0.14
|
2010-08-30
|
2010-05-17
|
0.14
|
2010-06-01
|
2010-02-12
|
0.14
|
2010-03-01
|
2009-11-16
|
0.14
|
2009-11-30
|
2009-08-17
|
0.14
|
2009-08-31
|
2009-05-11
|
0.14
|
2009-05-26
|
2009-02-13
|
0.14
|
2009-03-02
|
2008-11-10
|
0.14
|
2008-11-24
|
2008-08-11
|
0.14
|
2008-08-25
|
2008-05-12
|
0.14
|
2008-05-27
|
2008-02-11
|
0.14
|
2008-02-25
|
2007-11-08
|
0.14
|
2007-11-26
|
2007-08-09
|
0.14
|
2007-08-24
|
2007-05-14
|
0.14
|
2007-05-29
|
2007-02-09
|
0.14
|
2007-02-26
|
2006-11-10
|
0.14
|
2006-11-27
|
2006-08-10
|
0.14
|
2006-08-25
|
2006-05-15
|
0.14
|
2006-05-30
|
2006-02-10
|
0.14
|
2006-02-27
|
2005-11-09
|
0.14
|
2005-11-25
|
2005-07-28
|
0.14
|
2005-08-12
|
2005-05-12
|
0.14
|
2005-05-27
|
2005-02-17
|
0.14
|
2005-03-04
|
2004-11-10
|
0.14
|
2004-11-26
|
2004-07-29
|
0.14
|
2004-08-13
|
2004-05-13
|
0.14
|
2004-05-28
|
2004-02-19
|
0.14
|
2004-03-05
|
2003-11-06
|
0.14
|
2003-11-21
|
2003-07-31
|
0.14
|
2003-08-15
|
2003-05-08
|
0.14
|
2003-05-23
|
2003-02-12
|
0.14
|
2003-02-28
|
2002-11-06
|
0.14
|
2002-11-22
|
2002-08-01
|
0.14
|
2002-08-16
|
2002-05-09
|
0.14
|
2002-05-24
|
2002-02-13
|
0.14
|
2002-03-01
|
2001-11-07
|
0.14
|
2001-11-23
|
2001-08-02
|
0.14
|
2001-08-17
|
2001-05-10
|
0.14
|
2001-05-25
|
2001-02-21
|
0.14
|
2001-03-06
|
2000-11-08
|
0.14
|
2000-11-20
|
2000-08-03
|
0.14
|
2000-08-18
|
2000-05-11
|
0.14
|
2000-05-26
|
2000-02-10
|
0.14
|
2000-02-25
|
1999-11-10
|
0.14
|
1999-11-26
|
1999-08-12
|
0.14
|
1999-08-26
|
1999-05-13
|
0.14
|
1999-05-28
|
1999-02-10
|
0.14
|
1999-02-26
|
1998-11-12
|
0.14
|
1998-11-27
|
1998-08-06
|
0.13
|
1998-08-21
|
1998-05-14
|
0.13
|
1998-05-29
|
1998-02-11
|
0.13
|
1998-02-27
|
1997-11-06
|
0.13
|
1997-11-21
|
1997-08-07
|
0.11
|
1997-08-22
|
1997-05-08
|
0.11
|
1997-05-23
|
1997-02-12
|
0.11
|
1997-02-28
|
1996-11-14
|
0.11
|
1996-11-29
|
1996-08-08
|
0.09
|
1996-08-23
|
1996-05-09
|
0.09
|
1996-05-24
|
1996-02-14
|
0.09
|
1996-03-01
|
1995-11-16
|
0.09
|
1995-11-30
|
1995-08-11
|
0.09
|
1995-08-28
|
1995-05-05
|
0.09
|
1995-05-23
|
1995-02-13
|
0.09
|
1995-03-02
|
1994-11-14
|
0.08
|
1994-11-29
|
1994-08-15
|
0.08
|
1994-08-30
|
1994-05-11
|
0.08
|
1994-05-31
|
1994-02-14
|
0.08
|
1994-03-01
|
1993-10-29
|
0.07
|
1993-11-16
|
1993-08-11
|
0.07
|
1993-08-31
|
1993-05-05
|
0.07
|
1993-05-26
|
1993-02-10
|
0.07
|
1993-03-02
|
1992-11-09
|
0.06
|
1992-11-27
|
1992-08-06
|
0.06
|
1992-08-25
|
1992-05-06
|
0.25
|
1992-05-26
|
1992-02-11
|
0.25
|
1992-03-03
|
1991-11-13
|
0.22
|
1991-12-03
|
1991-08-07
|
0.22
|
1991-08-26
|
1991-05-07
|
0.22
|
1991-05-27
|
1991-02-12
|
0.22
|
1991-03-04
|
1990-11-08
|
0.18
|
1990-11-28
|
1990-08-17
|
0.18
|
1990-09-06
|
1990-05-11
|
0.18
|
1990-05-31
|
1990-02-15
|
0.18
|
1990-03-08
|
1989-11-08
|
0.15
|
1989-11-28
|
1989-08-11
|
0.15
|
1989-08-31
|
1989-05-12
|
0.15
|
1989-06-01
|
1989-02-22
|
0.15
|
1989-03-14
|
1988-11-10
|
0.13
|
1988-12-01
|
1988-08-09
|
0.13
|
1988-08-30
|
1988-05-20
|
0.13
|
1988-06-09
|
1988-02-16
|
0.13
|
1988-03-08
|
1987-11-10
|
0.11
|
1987-12-01
|
1987-07-31
|
0.11
|
1987-08-19
|
1987-05-15
|
0.11
|
1987-06-04
|
1987-02-26
|
0.11
|
1987-03-17
|
1986-11-12
|
0.10
|
1986-12-02
|
1986-08-08
|
0.10
|
1986-08-27
|
1986-05-14
|
0.10
|
1986-06-03
|
1986-02-25
|
0.10
|
1986-03-14
|
1985-11-06
|
0.09
|
1985-11-26
|
1985-07-30
|
0.09
|
1985-08-20
|
1985-05-14
|
0.09
|
1985-05-31
|
1985-02-15
|
0.09
|
1985-03-12
|
1984-11-15
|
0.08
|
1984-12-04
|
1984-08-15
|
0.08
|
1984-08-31
|
1984-05-10
|
0.08
|
1984-05-30
|
1984-03-06
|
0.08
|
1984-03-27
|
1983-11-09
|
0.07
|
1983-11-30
|
1983-08-10
|
0.06
|
1983-08-30
|
1983-05-11
|
0.06
|
1983-06-01
|
1983-02-28
|
0.06
|
1983-03-18
|
1982-11-09
|
0.06
|
1982-11-30
|
1982-08-12
|
0.06
|
1982-09-01
|
1982-05-12
|
0.06
|
1982-06-02
|
1982-03-18
|
0.06
|
1982-04-08
|
1981-11-10
|
0.11
|
1982-01-05
|
1981-08-12
|
0.11
|
1981-09-01
|
1981-05-14
|
0.11
|
1981-06-02
|
1981-03-11
|
0.11
|
1981-03-31
|
1980-11-13
|
0.09
|
1980-12-02
|
1980-08-14
|
0.09
|
1980-09-03
|
1980-05-15
|
0.09
|
1980-06-03
|
1980-03-09
|
0.09
|
1980-03-26
|
1979-11-07
|
0.08
|
1979-11-27
|
1979-08-08
|
0.08
|
1979-08-27
|
1979-05-21
|
0.08
|
1979-06-11
|
1979-03-18
|
0.08
|
1979-04-03
|
1978-11-08
|
0.08
|
1978-11-27
|
1978-08-09
|
0.06
|
1978-08-29
|
1978-05-10
|
0.06
|
1978-05-30
|
1978-03-08
|
0.06
|
1978-03-28
|
1977-11-09
|
0.04
|
1977-11-29
|
1977-08-09
|
0.04
|
1977-08-30
|
1977-05-09
|
0.04
|
1977-05-30
|
1977-03-02
|
0.04
|
1977-03-23
|
